Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study.
De Luca L, Temporelli PL, Gulizia MM, Gonzini L, Ammaturo TA, Tedesco L, Pede S, Oliva F, Gabrielli D, Colivicchi F, Averna MR; START Investigators. De Luca L, et al. Among authors: temporelli pl. Nutr Metab Cardiovasc Dis. 2023 Dec;33(12):2398-2405. doi: 10.1016/j.numecd.2023.07.036. Epub 2023 Aug 7. Nutr Metab Cardiovasc Dis. 2023. PMID: 37788956
Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registry.
De Luca L, Gulizia MM, Gabrielli D, Meessen J, Mattei L, D'Urbano M, Colivicchi F, Temporelli PL, Borghi C, Desideri G; START Investigators. De Luca L, et al. Among authors: temporelli pl. Nutr Metab Cardiovasc Dis. 2022 Feb;32(2):393-401. doi: 10.1016/j.numecd.2021.09.034. Epub 2021 Oct 16. Nutr Metab Cardiovasc Dis. 2022. PMID: 34893417
Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START Study.
De Luca L, Temporelli PL, Colivicchi F, Gonzini L, Fasano ML, Pantaleoni M, Greco G, Oliva F, Gabrielli D, Gulizia MM. De Luca L, et al. Among authors: temporelli pl. Front Cardiovasc Med. 2022 Apr 13;9:874087. doi: 10.3389/fcvm.2022.874087. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35498014 Free PMC article.
Current management and treatment of patients with stable coronary artery diseases presenting to cardiologists in different clinical contexts: A prospective, observational, nationwide study.
De Luca L, Temporelli PL, Lucci D, Gonzini L, Riccio C, Colivicchi F, Geraci G, Formigli D, Maras P, Falcone C, Di Lenarda A, Gulizia MM; START Investigators. De Luca L, et al. Among authors: temporelli pl. Eur J Prev Cardiol. 2018 Jan;25(1):43-53. doi: 10.1177/2047487317740663. Epub 2017 Nov 10. Eur J Prev Cardiol. 2018. PMID: 29124952
Characteristics, treatment and quality of life of stable coronary artery disease patients with or without angina: Insights from the START study.
De Luca L, Temporelli PL, Lucci D, Colivicchi F, Calabrò P, Riccio C, Amico A, Mascia F, Proia E, Di Lenarda A, Gulizia MM; START Investigators. De Luca L, et al. Among authors: temporelli pl. PLoS One. 2018 Jul 12;13(7):e0199770. doi: 10.1371/journal.pone.0199770. eCollection 2018. PLoS One. 2018. PMID: 30001355 Free PMC article.
Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
De Luca L, Arca M, Temporelli PL, Colivicchi F, Gonzini L, Lucci D, Bosco B, Callerame M, Lettica GV, Di Lenarda A, Gulizia MM; START Investigators. De Luca L, et al. Among authors: temporelli pl. Clin Cardiol. 2018 Aug;41(8):1075-1083. doi: 10.1002/clc.23031. Epub 2018 Aug 20. Clin Cardiol. 2018. PMID: 30039543 Free PMC article.
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.
De Luca L, Temporelli PL, Riccio C, Gonzini L, Marinacci L, Tartaglione SN, Costa P, Scherillo M, Senni M, Colivicchi F, Gulizia MM; START Investigators. De Luca L, et al. Among authors: temporelli pl. Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):334-342. doi: 10.1093/ehjqcco/qcz002. Eur Heart J Qual Care Clin Outcomes. 2019. PMID: 30649303
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry.
De Luca L, Arca M, Temporelli PL, Meessen J, Riccio C, Bonomo P, Colavita AR, Gabrielli D, Gulizia MM, Colivicchi F; START Investigators. De Luca L, et al. Among authors: temporelli pl. Int J Cardiol. 2020 Oct 1;316:229-235. doi: 10.1016/j.ijcard.2020.05.055. Epub 2020 May 26. Int J Cardiol. 2020. PMID: 32470532
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry.
De Luca L, Formigli D, Meessen J, Uguccioni M, Cosentino N, Paolillo C, Di Lenarda A, Colivicchi F, Gabrielli D, Gulizia MM, Scherillo M; START Investigators. De Luca L, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):513-520. doi: 10.1093/ehjqcco/qcaa054. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32559279
184 results